OneThree Biotech is a biology-driven artificial intelligence platform that optimizes drug discovery and development.
OneThree Biotech is working to change how new medicines are discovered using biology-driven AI.
OneThree Biotech was co-founded in 2018 by Neel S. Madhukar, Coryandar Gilvary, Bradlay Pryde, and Olivier Elemento. The company is headquartered in New York.
OneThree Biotech (OTB) is a graduate of Cornell Tech's Runway Startup program. They were selected as part of the 2020 class of startups for Grand Central Tech and the platform has won awards such as "Most Innovative Technology" award at the 2019 InnoHubei International Science and Technology Innovation and Entrepreneurship Competition.
OneThree Biotech has raised $2.5M in a Seed round on Mar 26, 2020. The investment was backed by Primary Venture Partners and Meridian Street Capital.